Skip to main content
Milind Desai, MD, Cardiology, Cleveland, OH, Cleveland Clinic

MilindYDesaiMDMBA

Cardiology Cleveland, OH

Cardiothoracic Imaging, Non-Invasive Cardiology, Cardiovascular Disease Genetics

Director of Clinical Operations, Department of Cardiovascular Medicine, Cleveland Clinic, Haslam Family Endowed Chair in CV Medicine, Professor of Medicine, Case Western Reserve University School of Medicine

Dr. Desai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Desai's full profile

Already have an account?

Summary

  • https://my.clevelandclinic.org/staff/6670-milind-desai

Education & Training

  • Haslam School of Business, University of Tennessee
    Haslam School of Business, University of TennesseeMBA, 2020 - 2020
  • Wharton School of Business, University of Pennsylvania
    Wharton School of Business, University of PennsylvaniaCertificate: Physician Leadership Academy, 2018 - 2019
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Advanced Cardiac Imaging, 2004 - 2005
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2003 - 2004
  • Allegheny Health Network Medical Education Consortium (AGH)
    Allegheny Health Network Medical Education Consortium (AGH)Fellowship, Cardiovascular Disease, 2001 - 2003
  • Southern Illinois University
    Southern Illinois UniversityResidency, Internal Medicine, 1994 - 1997
  • N.H.L Municipal Medical College
    N.H.L Municipal Medical CollegeClass of 1994

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2006 - 2025
  • OH State Medical License
    OH State Medical License 2005 - 2025
  • MI State Medical License
    MI State Medical License 2006 - 2023
  • NY State Medical License
    NY State Medical License 2006 - 2019
  • MD State Medical License
    MD State Medical License 2003 - 2006
  • PA State Medical License
    PA State Medical License 2001 - 2004
  • MA State Medical License
    MA State Medical License 1999 - 2004
  • American Board of Internal Medicine Cardiovascular Disease
  • Join now to see all

Awards, Honors, & Recognition

  • FAHA
  • FESC
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients with SARS-CoV-2 Infection  
    Reena Mehra, Milind Y Desai, JAMA Network Open
  • State-of-the-Art Review Decision Making with Imaging in Asymptomatic Aortic Regurgitation  
    Zoran B Popovic, Milind Y Desai, Brian P Griffin, ScienceDirect
  • Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy  
    Milind Y Desai, Zoran B Popovic, Harry M Lever, Divyanshu Mohananey, ScienceDirect
  • Join now to see all

Abstracts/Posters

  • [Board 547] Characteristics and Outcomes of Patients With Documented Stress Induced (Takotsubo) Cardiomyopathy: A Tertiary Care Center Experience
    Milind Desai, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
  • [Board 548] Characteristics and Longer-Term Outcomes of Pediatric Patients With Hypertrophic Cardiomyopathy: A Tertiary Care Center Experience
    Milind Desai, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Press Mentions

  • Advances in HF, Hypertrophic Cardiomyopathy Management Among Top News of 2022
    Advances in HF, Hypertrophic Cardiomyopathy Management Among Top News of 2022January 5th, 2023
  • ACC22: Transforming Cardiovascular Care
    ACC22: Transforming Cardiovascular CareMay 11th, 2022
  • Cardiac Myosin Inhibitor Gets FDA's Blessing for Obstructive HCM
    Cardiac Myosin Inhibitor Gets FDA's Blessing for Obstructive HCMApril 29th, 2022
  • Join now to see all

Professional Memberships

Other Languages

  • Hindi, Gujarati

Hospital Affiliations